Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 50

Sort by

Sort Order Select

Journal Articles

Impact of COVID-19 infection on hospitalization outcomes in patients with myeloproliferative neoplasms: Analysis of the national inpatient sample 2020–2021

Evani Jain, Anirudh Jain, Chiranjeevi Sainatham, Prashant Chaulagain, Forat Lutfi

Blood (2025) 146 (Supplement 1): 7319.

https://doi.org/10.1182/blood-2025-7319

Published: 2025

Journal Articles

Outcomes after bone marrow versus peripheral blood mismatched unrelated donor hematopoietic cell transplantation using posttransplant cyclophosphamide-based GVHD prophylaxis

Amir Kasaeian, Moazzam Shahzad, Zeeshan Sattar, Muhammad Kashif Amin, Hediyeh Alemi, Forat Lutfi, Mehdi Hamadani, Rajat Bansal, Alma Habib, Joseph McGuirk, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 934.

https://doi.org/10.1182/blood-2025-934

Published: 2025

Journal Articles

Toxicity and efficacy profile of cardioprotective vs conventional doxorubicin: A meta-analysis

Evani Jain, Anirudh Jain, Chiranjeevi Sainatham, Omesh Prathiraja, Khalid Elhassan, Akash Khehra, Forat Lutfi

Blood (2025) 146 (Supplement 1): 6167.

https://doi.org/10.1182/blood-2025-6167

Published: 2025

Journal Articles

Pre-infusion ADAMTS13 and VWF levels are associated with clinical outcomes of patients receiving CAR-T cell therapy

Abdalla Shoaib, Sarah Gralnek, Forat Lutfi, Haitham Abdelhakim, X. Long Zheng

Blood (2025) 146 (Supplement 1): 2339.

https://doi.org/10.1182/blood-2025-2339

Published: 2025

Journal Articles

Absolute lymphocyte count (ALC) at apheresis and infusion as a predictor of safety and efficacy for multiple myeloma and B cell malignancies post CAR-T therapy

Raeef Rahman, Isuru Ratnayake, Jianzheng Wu, Lauren Scott, William Wesson, Razan Mansour, Marc Hoffmann, Aung Tun, Joseph Bennett, Al-Ola Abdallah, Muhammad Mushtaq, Dinesh Mudaranthakam, Joseph McGuirk, Nausheen Ahmed, Forat Lutfi

Blood (2025) 146 (Supplement 1): 7630.

https://doi.org/10.1182/blood-2025-7630

Published: 2025

Journal Articles

Parkinsonism and other non-immune effector cell-associated neurotoxicities related to BCMA-directed chimeric antigen receptor T-cell therapy

Paul Worsley, Jianzheng Wu, Isuru Ratnayake, Dinesh Mudaranthakam, Al-Ola Abdallah, Jeries Kort, Evguenia Bhurtel, Leyla Shune, Joseph McGuirk, Muhammad Nashatizadeh, Nausheen Ahmed, Forat Lutfi

Blood (2025) 146 (Supplement 1): 2389.

https://doi.org/10.1182/blood-2025-2389

Published: 2025

Journal Articles

The durability of consolidative transplant in mediastinal gray zone lymphoma, a single institution retrospective

Neda Amirmokhtari, Jianzheng Wu, Marc Hoffmann, Aung Tun, Joseph Bennett, Nausheen Ahmed, Muhammad Umair Mushtaq, Shaun DeJarnette, Forat Lutfi

Blood (2025) 146 (Supplement 1): 7197.

https://doi.org/10.1182/blood-2025-7197

Published: 2025

Journal Articles

Pooled analysis of early-Phase trials highlights robust activity of CD3-CD20 T-cell engagers in follicular lymphoma

Suhib Fahmawi, Forat Lutfi, Jood Ahmad, Nahid Suleman

Blood (2025) 146 (Supplement 1): 5387.

https://doi.org/10.1182/blood-2025-5387

Published: 2025

Journal Articles

Intrathecal chemotherapy for management of immune effector cell-associated neurotoxicity syndrome (ICANS): A multi-center, real-world analysis of clinical outcomes

Adam Kidwell, Karolina Lungova, Aniko Szabo, Emilie Aschenbrenner, Timothy Schieber, Forat Lutfi, Wilder Widman, Austin Quick, Ashley Dunton, Bhagirathbhai Dholaria, Olalekan Oluwole, Rita Ahmad, Seth Maliske, Caitlin Guzowski, Scott Solomon, Melissa Babcook, Nathan Denlinger, Nirav Shah

Blood (2025) 146 (Supplement 1): 6302.

https://doi.org/10.1182/blood-2025-6302

Published: 2025

Journal Articles

Pre-CAR-T pulmonary function test and respiratory comorbidities have limited predictive value for survival, toxicities, and respiratory complications

Yuanli Lei, Muhammad Atif Khan, Aqsa Ashraf, Noha Soror, Muhammad Salman Faisal, Jennifer Holter-Chakrabarty, Adam Asch, Forat Lutfi, Rachel Dileo, Sami Ibrahimi, Manu Pandey, Mohamad Khawandanah, Silas Day, Huimin Wu, Prerna Mewawalla, Nausheen Ahmed, Taha Al-Juhaishi

Blood (2025) 146 (Supplement 1): 2373.

https://doi.org/10.1182/blood-2025-2373

Published: 2025

Journal Articles

Sociodemographic and patient-related determinants of outcomes after unrelated donor hematopoietic cell transplantation using posttransplant cyclophosphamide-based GVHD prophylaxis

Moazzam Shahzad, Aqeeb Ur Rehman, Shah Rukh, Muhammad Kashif Amin, Amir Kasaeian, Hammad Shafi, Forat Lutfi, Mehdi Hamadani, Joseph McGuirk, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 7684.

https://doi.org/10.1182/blood-2025-7684

Published: 2025

Journal Articles

Incidence, outcomes and economic burden of cytokine release syndrome and immune effector cell associated neurotoxicity syndrome in patients undergoing CAR-T cell therapy for multiple myeloma

Evani Jain, Anirudh Jain, Chiranjeevi Sainatham, Forat Lutfi

Blood (2025) 146 (Supplement 1): 4017.

https://doi.org/10.1182/blood-2025-4017

Published: 2025

Journal Articles

Impact of Absolute Lymphocyte Count on Efficacy and Toxicity of T-Cell Engagers in Non-Hodgkin's Lymphoma

Jordan Snyder, Nausheen Ahmed, Aqeeb Ur Rehman, Muhammad Umair Mushtaq, Aung M. Tun, Al-Ola Abdallah, Marc Hoffmann, Forat Lutfi

Blood (2024) 144 (Supplement 1): 7731.

https://doi.org/10.1182/blood-2024-207753

Published: 2024

Journal Articles

Absolute Lymphocyte Count As a Predictor of Safety and Efficacy Post CART for Multiple Myeloma and B Cell Malignancies

Raeef L Rahman, Jianzheng Wu, Lauren N Scott, William Wesson, Razan Mansour, Aung M. Tun, Marc Hoffmann, Al-Ola Abdallah, Dinesh Pal Mudaranthakam, Joseph P. McGuirk, Nausheen Ahmed, Forat Lutfi

Blood (2024) 144 (Supplement 1): 7099.

https://doi.org/10.1182/blood-2024-205978

Published: 2024

Journal Articles

The Scope of Academic and Industry Sponsorship in Shaping the Future of AL Amyloidosis Research

Anas Zayad, Nausheen Ahmed, Zahra Mahmoudjafari, Muhammad Umair Mushtaq, Evguenia Ouchveridze, Forat Lutfi, Joseph P. McGuirk, Al-Ola Abdallah, Faiz Anwer, Manisha Bhutani, Shebli Atrash

Blood (2024) 144 (Supplement 1): 7595.

https://doi.org/10.1182/blood-2024-205422

Published: 2024

Journal Articles

Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS) for Chimeric Antigen Receptor T-Cell Therapy (CAR-T) and T-Cell Engager Antibody (TCE) in Myeloma and Lymphoma

Fathima Shehnaz Ayoobkhan, Raabia Qureshi, Raeef L Rahman, Zohaa Faiz, Sohaib Irfan, Ahmad Iftikhar, Briha Ansari, Muhammad Umair Mushtaq, Al-Ola Abdallah, Shahzad Raza, Hira Shaikh, Forat Lutfi, Shebli Atrash, Joseph P. McGuirk, Hamza Hashmi, Faiz Anwer, Nausheen Ahmed

Blood (2024) 144 (Supplement 1): 5163.

https://doi.org/10.1182/blood-2024-208307

Published: 2024

Journal Articles

Global Trends of Burden of Chronic Myeloid Leukemia Based on Socio-Demographic Index (SDI): A Comparative Epidemiological Study

Prashant Chaulagain, Ashmita Poudel, Saurav Aryal, Chiranjeevi Sainatham, Forat Lutfi

Blood (2024) 144 (Supplement 1): 7918.

https://doi.org/10.1182/blood-2024-210443

Published: 2024

Journal Articles

Incidence and Severity of Cytopenias Secondary to CD19-Targeted CAR-T Cell Therapy: A Systemic Review and Meta-Analysis

Blood (2024) 144 (Supplement 1): 7242.

https://doi.org/10.1182/blood-2024-206536

Published: 2024

Journal Articles

Avascular Necrosis (AVN) Outcomes in Allogeneic Stem Cell Transplant Recipients

Blood (2024) 144 (Supplement 1): 7414.

https://doi.org/10.1182/blood-2024-206235

Published: 2024

Journal Articles

Sociodemographic Determinants of Allogeneic Hematopoietic Stem Cell Transplant Outcomes

Matthew McGuirk, Moazzam Shahzad, Sohaib Irfan, Muhammad Kashif Amin, Sibgha Gull Chaudhary, Iqra Anwar, Shaun DeJarnette, Forat Lutfi, Al-Ola Abdallah, Anurag K. Singh, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2024) 144 (Supplement 1): 7410.

https://doi.org/10.1182/blood-2024-193655

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Impact of COVID-19 infection on hospitalization outcomes in patients with myeloproliferative neoplasms: Analysis of the national inpatient sample 2020–2021

Outcomes after bone marrow versus peripheral blood mismatched unrelated donor hematopoietic cell transplantation using posttransplant cyclophosphamide-based GVHD prophylaxis

Toxicity and efficacy profile of cardioprotective vs conventional doxorubicin: A meta-analysis

Pre-infusion ADAMTS13 and VWF levels are associated with clinical outcomes of patients receiving CAR-T cell therapy

Absolute lymphocyte count (ALC) at apheresis and infusion as a predictor of safety and efficacy for multiple myeloma and B cell malignancies post CAR-T therapy

Parkinsonism and other non-immune effector cell-associated neurotoxicities related to BCMA-directed chimeric antigen receptor T-cell therapy

The durability of consolidative transplant in mediastinal gray zone lymphoma, a single institution retrospective

Pooled analysis of early-Phase trials highlights robust activity of CD3-CD20 T-cell engagers in follicular lymphoma

Intrathecal chemotherapy for management of immune effector cell-associated neurotoxicity syndrome (ICANS): A multi-center, real-world analysis of clinical outcomes

Pre-CAR-T pulmonary function test and respiratory comorbidities have limited predictive value for survival, toxicities, and respiratory complications

Sociodemographic and patient-related determinants of outcomes after unrelated donor hematopoietic cell transplantation using posttransplant cyclophosphamide-based GVHD prophylaxis

Incidence, outcomes and economic burden of cytokine release syndrome and immune effector cell associated neurotoxicity syndrome in patients undergoing CAR-T cell therapy for multiple myeloma

Impact of Absolute Lymphocyte Count on Efficacy and Toxicity of T-Cell Engagers in Non-Hodgkin's Lymphoma

Absolute Lymphocyte Count As a Predictor of Safety and Efficacy Post CART for Multiple Myeloma and B Cell Malignancies

The Scope of Academic and Industry Sponsorship in Shaping the Future of AL Amyloidosis Research

Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS) for Chimeric Antigen Receptor T-Cell Therapy (CAR-T) and T-Cell Engager Antibody (TCE) in Myeloma and Lymphoma

Global Trends of Burden of Chronic Myeloid Leukemia Based on Socio-Demographic Index (SDI): A Comparative Epidemiological Study

Incidence and Severity of Cytopenias Secondary to CD19-Targeted CAR-T Cell Therapy: A Systemic Review and Meta-Analysis

Avascular Necrosis (AVN) Outcomes in Allogeneic Stem Cell Transplant Recipients

Sociodemographic Determinants of Allogeneic Hematopoietic Stem Cell Transplant Outcomes

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only